Tag: biotechnology
-
Exosome Technology Acquired for TBI, Stroke Therapies
A company developing therapies for brain injuries and neurodegenerative disorders is acquiring the rights to a process that treats these conditions with pieces of RNA transferred in tiny containers call exosomes.
-
RNA Nanoparticles Designed for Brain Cancer Therapy
Medical researchers and material scientists devised a technique for delivering tiny particles of genetic material to the brain, which help lab mice shrink or remove their brain tumors and survive longer.
-
FDA Issues Draft Gene Therapy Regulatory Guidance
FDA issued a series of draft documents spelling out its processes for reviewing gene therapies for three types of diseases, as well as producing and testing these treatments.
-
Nanoparticles Shown to Boost Anti-Cancer Immune Cells
A bioengineering lab developed a technique to attach larger quantities of cancer-fighting proteins to immune system cells that in lab mice reduced or eliminated tumors while avoiding harmful side effects.
-
Gene Therapy Shown to Reduce Extreme High Cholesterol
A gene therapy technique that stops production of a targeted protein is shown in tests with monkeys to reduce levels of harmful cholesterol, but also expose potential risks associated with the technique.
-
Crispr Deployed to Boost Plant Disease Resistance
A plant science lab in Dallas is designing a new use of the emerging genome editing technique known as Crispr to add more resistance to plant diseases in two staple food crops.
-
NIH Grant Funds New Spinal Cord Injury Treatment
A biotechnology company developing regenerative therapies for neurological disorders is receiving a Small Business Innovation Research grant to advance an experimental treatment for spinal cord injury.
-
Engineered Polio Virus Tested as Brain Cancer Treatment
Results of a clinical trial show a genetically engineered polio virus helps more people with glioblastoma, an aggressive form of brain cancer, survive for longer periods.
-
Univ. Spin-Off Developing Long-Lasting Diabetes Drug
A company spun-off from a University at Buffalo biochemistry lab is the recipient of a small business grant to design a once-a-week drug for people with type 2 diabetes to control their blood sugar and weight.
-
$3.4M NIH Grant Funding New ALS Treatments
A biotechnology company is receiving a grant from National Institute of Neurological Disorders and Stroke to advance its experimental treatments for amyotrophic lateral sclerosis, or ALS.